Search Within

Maria C Pietanza

Formats
  1. Meeting Abstract (67)
  2. Journal Article (50)
  3. Book Section (4)
  4. Correspondence (1)
Groups
  1. Department of Medicine (84)
  2. Solid Tumor Oncology Division (81)
  3. Thoracic Oncology (75)
  4. Department of Pathology and Laboratory Medicine (50)
  5. GSK Faculty (48)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)

More Groups

People
  1. Mark Kris (50)
  2. Lee Krug (37)
  3. Charles Rudin (33)
  4. William Travis (33)
  5. Gregory Riely (27)
  6. Natasha Rekhtman (24)

More People

Years
  1. 2019 (2)
  2. 2018 (2)
  3. 2017 (8)
  4. 2016 (16)
  5. 2015 (24)
  6. 2014 (15)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Journal of Thoracic Oncology (26)
  3. Modern Pathology (8)
  4. International Journal of Radiation Oncology, Biology, Physics (6)
  5. Laboratory Investigation (6)
  6. Annals of Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (39)
  2. American Society of Clinical Oncology (29)
  3. Nature Publishing Group (8)
  4. Nature Research (8)
  5. Oxford University Press (6)
  6. American Association for Cancer Research (5)

More Publishers

Results (122)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Azzoli, C. G.; Pietanza, M.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Miller, V. A.; Pao, W.; Ginsberg, M. S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • EGFR mutations in men and cigarette smokers with lung adenocarcinoma
    Meeting Abstract

    Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Use of PET-measured response in involved mediastinal lymph nodes to predict overall survival (OS) in non-small cell lung cancer (NSCLC) patients treated with induction therapy (IT) and surgery
    Meeting Abstract

    Barnett, S.; Plourde, G.; Zheng, J.; Pietanza, M.; Akhurst, T. J.; Downey, R. J.; Kris, M. G.; Shen, R.; Rusch, V. W.; Park, B. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer
    Meeting Abstract

    Pietanza, M. C.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
    Pancreas (2010)

    Fulltext@MSK | Save
  • Selective pressure for the EGFR T790M resistance mutation may be different for different EGFR tyrosine kinase inhibitors
    Meeting Abstract

    Chmielecki, J.; Pietanza, M. C.; Kris, M.; Miller, V.; Pao, W.
    Journal of Thoracic Oncology (2010)

    Fulltext@MSK | Save
  • Leptomeningeal metastases from small cell lung cancer responsive to temozolomide therapy
    Journal Article

    Zauderer, M.; Krug, L. M.; Pietanza, M. C.; O'rourke, D.
    Journal of Thoracic Oncology (2010)

    Fulltext@MSK | Save
  • Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer
    Journal Article

    Price, K. A.; Azzoli, C. G.; Krug, L. M.; Pietanza, M. C.; Rizvi, N. A.; Pao, W.; Kris, M. G.; Riely, G. J.; Heelan, R. T.; Arcila, M. E.; more...
    Journal of Thoracic Oncology (2010)

    Fulltext@MSK | Save
  • Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
    Journal Article

    De Braganca, K. C.; Janjigian, Y. Y.; Azzoli, C. G.; Kris, M.; Pietanza, M. C.; Nolan, C.; Omuro, A. M.; Holodny, A.; Lassman, A. B.
    Journal of Neuro-Oncology (2010)

    Fulltext@MSK | Save
  • The molecular pathogenesis of small cell lung cancer
    Journal Article

    D'Angelo, S. P.; Pietanza, M. C.
    Cancer Biology and Therapy (2010)

    Fulltext@MSK | Save
  • Phase 1 trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Meeting Abstract

    Riely, G. J.; Janjigian, Y. Y.; Pereira, L. K.; Azzoli, C. G.; Pietanza, M. C.; Krug, L. M.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save